ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novo Holdings establishes rare bleeding disorder firm Hemab
December 16, 2020Novo Holdings’ early-stage investment and company creation team Novo Seeds has established a new portfolio company – Hemab – which will focus on the development of bispecific antibodies for rare bleeding disorders. -
CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019
July 05, 2019Global biotherapeutics leader CSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation factor programs at ...
Pharma Sources Insight January 2025
